1. Home
  2. EPM vs EOLS Comparison

EPM vs EOLS Comparison

Compare EPM & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$4.07

Market Cap

136.3M

Sector

Energy

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.99

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
EOLS
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.3M
444.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EPM
EOLS
Price
$4.07
$6.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$4.75
$20.80
AVG Volume (30 Days)
404.6K
1.1M
Earning Date
11-11-2025
11-05-2025
Dividend Yield
11.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$85,232,000.00
$285,823,000.00
Revenue This Year
N/A
$14.36
Revenue Next Year
$2.97
$23.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.10
52 Week Low
$3.71
$5.71
52 Week High
$5.70
$17.12

Technical Indicators

Market Signals
Indicator
EPM
EOLS
Relative Strength Index (RSI) 45.32 52.83
Support Level $4.02 $6.83
Resistance Level $4.27 $7.29
Average True Range (ATR) 0.10 0.25
MACD 0.04 0.01
Stochastic Oscillator 62.00 68.82

Price Performance

Historical Comparison
EPM
EOLS

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: